PBPH
Portfolio Building Block World Pharma And Biotech Index ETF
Price Chart
Latest Quote
$25.55
+0.32 (+1.26%)
Current Price
| Previous Close | $25.23 |
| Open | $25.26 |
| Day High | $25.61 |
| Day Low | $25.26 |
| Volume | 102,248 |
Fund Information
| Net Assets | $789.32M |
| Expense Ratio | 0.13% |
| Category | Health |
| Fund Family | Portfolio Building Block ETFs |
| Net Asset Value | $25.19 |
| Premium/Discount | 1.42% |
| P/E Ratio | 23.41 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $25.57 |
| SMA50 | $25.30 |
| RSI | 56.34 |
| ATR | 0.3826 |
| Rel Volume | 1.31 |
Performance History
| Week | -1.61% |
| Month | +1.21% |
| Quarter | +4.05% |
| 6 Months | +3.04% |
| YTD | +0.93% |
| 10 Years | +3.16% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $25.55 | 102,248 |
| 2026-06-18 | $25.25 | 82,100 |
| 2026-06-17 | $25.59 | 94,600 |
| 2026-06-16 | $25.67 | 80,300 |
| 2026-06-15 | $25.70 | 65,400 |
| 2026-06-12 | $25.97 | 79,100 |
| 2026-06-11 | $26.08 | 94,900 |
| 2026-06-10 | $25.54 | 50,400 |
| 2026-06-09 | $25.74 | 75,000 |
| 2026-06-08 | $25.59 | 76,100 |
| 2026-06-05 | $25.81 | 74,500 |
| 2026-06-04 | $25.68 | 85,700 |
| 2026-06-03 | $24.96 | 60,900 |
| 2026-06-02 | $24.81 | 76,700 |
| 2026-06-01 | $25.10 | 86,600 |
| 2026-05-29 | $25.70 | 81,400 |
| 2026-05-28 | $25.86 | 75,700 |
| 2026-05-27 | $25.67 | 66,700 |
| 2026-05-26 | $25.52 | 77,800 |
About Portfolio Building Block World Pharma And Biotech Index ETF
The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.